Login

Christoph Vilanek of Freenet AG speaks at the 25 Years MCI event, while Thierry Bernard, CEO of QIAGEN N.V., participates in the Distinguished Guest Livetalk. 00:10:00

Share On Facebook Share On Twitter

Christoph Vilanek, CEO of Freenet

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
USB4 Overview |Business Development Director, VIA Labs Inc
00:10:00
Optimizing Accuracy in Medical Transcription Through Dual AI Model Integration| Manny Krakaris , CEO, Augmedix Inc.
00:10:00
Xanadu Mines: Project Overview and Strategic Update
00:10:00
Maximizing Stock Option Strategies: Taxation, Net Worth, and Goals
00:10:00
American Lithium Corp.: Diverse Assets in Nevada and Peru, Poised for Growth
00:10:00
Andrea Frazzini of AQR Capital Management Explores the Practical Application of Academic Research in Generating Investment Returns: Insights from the Yale School of Management
00:10:00
Liberty Gold CEO Cal Everett on Market Cap, Cash Position, and Black Pine Economics
00:10:00
CEO Ton Hillen's Electric Ride: Insights on Sustainability and Challenges | Mr. A.G.J. (Ton) Hillen - CEO of Heijmans
00:10:00
With a low cost base, a strong and experienced organisational culture, combined with a unique capital structure|PATRICK SCHORN , CHIEF EXECUTIVE OFFICER AT BorrDrilling
00:10:00
"Leadership, for me, is about relationships. Understand the need of the person you're dealing with and find a way to fill it, fostering mutual respect and trust."|Jean-Louis Servranckx is President and Chief Executive Officer of Aecon Group Inc.
00:10:00
StateOfTheArt AI and ML- Investor's Perspectives|Matt Turck,Partner,FirstMark
00:10:00
Dan Bar-Holden Highlights Luca Mining's Strong Q2 Performance and Future Growth Plans

© 2017 - Neuhu+